{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:28:48Z","timestamp":1793917728818,"version":"4.8.0"},"reference-count":264,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.metabol.2018.11.001","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T02:33:16Z","timestamp":1542076396000},"page":"121-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1398,"special_numbering":"C","title":["Obesity and cancer risk: Emerging biological mechanisms and perspectives"],"prefix":"10.1016","volume":"92","author":[{"given":"Konstantinos I.","family":"Avgerinos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Spyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dalamaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2018.11.001_bb0005","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3928\/1081-597X-19980901-03","article-title":"Options for refractive surgery in 1998","volume":"14","author":"Probst","year":"1998","journal-title":"J Refract Surg"},{"key":"10.1016\/j.metabol.2018.11.001_bb0010","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.metabol.2018.01.001","article-title":"The role of extracellular and intracellular Nicotinamide phosphoribosyl-transferase in cancer: Diagnostic and therapeutic perspectives and challenges","volume":"82","author":"Dalamaga","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2018.11.001_bb0020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/er.2011-1015","article-title":"The role of adiponectin in cancer: a review of current evidence","volume":"33","author":"Dalamaga","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1749-6632.2012.06750.x","article-title":"Obesity and cancer risk: evidence, mechanisms, and recommendations","volume":"1271","author":"Vucenik","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.metabol.2018.11.001_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canep.2016.01.003","article-title":"Obesity and cancer: an update of the global impact","volume":"41","author":"Arnold","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/nyas.12416","article-title":"Obesity and cancer pathogenesis","volume":"1311","author":"Berger","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.metabol.2018.11.001_bb0040","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/ijo.2008.102","article-title":"Global burden of obesity in 2005 and projections to 2030","volume":"32","author":"Kelly","year":"2008","journal-title":"Int J Obes"},{"key":"10.1016\/j.metabol.2018.11.001_bb0045","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2018.11.001_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-42542-9_1","article-title":"Obesity and risk of cancer: an introductory overview","volume":"208","author":"Pischon","year":"2016","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.metabol.2018.11.001_bb0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/obr.12629","article-title":"Obesity as a risk factor for Alzheimer's disease: weighing the evidence","volume":"19","author":"Alford","year":"2018","journal-title":"Obes Rev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mcna.2017.08.004","article-title":"Obesity as a disease","volume":"102","author":"Upadhyay","year":"2018","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.metabol.2018.11.001_bb0065","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb0070","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1200\/JCO.2014.58.4680","article-title":"American Society of Clinical Oncology position statement on obesity and cancer","volume":"32","author":"Ligibel","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0075","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2014viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb0080","author":"World Cancer Research Fund\/American Institute for Cancer Research"},{"key":"10.1016\/j.metabol.2018.11.001_bb0085","doi-asserted-by":"crossref","first-page":"j477","DOI":"10.1136\/bmj.j477","article-title":"Adiposity and cancer at major anatomical sites: umbrella review of the literature","volume":"356","author":"Kyrgiou","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2018.11.001_bb0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S2213-8587(17)30396-0","article-title":"Diabetes and adiposity: a heavy load for cancer","volume":"6","author":"Park","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0095","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/annonc\/mdv355","article-title":"Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies","volume":"26","author":"Genkinger","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1373\/clinchem.2017.277376","article-title":"Obesity and cancer: evidence, impact, and future directions","volume":"64","author":"Colditz","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2018.11.001_bb0105","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1158\/1055-9965.EPI-14-0909-T","article-title":"Early life body fatness and risk of colorectal cancer in U.S. women and men-results from two large cohort studies","volume":"24","author":"Zhang","year":"2015","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0110","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/aje\/kws295","article-title":"Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP diet and health study","volume":"177","author":"Hofmann","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0115","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1200\/JCO.2016.66.4391","article-title":"Trends in obesity prevalence in adults with a history of cancer: results from the us national health interview survey, 1997 to 2014","volume":"34","author":"Greenlee","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0120","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ijc.23943","article-title":"Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis","volume":"124","author":"Suzuki","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0125","series-title":"The obesity paradox in cancer: clinical insights and perspectives","first-page":"185","volume":"23","author":"Trestini","year":"2018"},{"key":"10.1016\/j.metabol.2018.11.001_bb0130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ypmed.2014.02.003","article-title":"The obesity paradox: understanding the effect of obesity on mortality among individuals with cardiovascular disease","volume":"62","author":"Banack","year":"2014","journal-title":"Prev Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb0135","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/eurheartj\/ehv414","article-title":"Protective overweight in cardiovascular disease: moving from 'paradox' to 'paradigm'","volume":"36","author":"Doehner","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2018.11.001_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-012-0059-5","article-title":"The obesity paradox in chronic disease: facts and numbers","volume":"3","author":"Lainscak","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.metabol.2018.11.001_bb0145","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.7754\/Clin.Lab.2012.121112","article-title":"Correlates of serum resistin in elderly, non-diabetic patients with chronic kidney disease","volume":"59","author":"Marouga","year":"2013","journal-title":"Clin Lab"},{"key":"10.1016\/j.metabol.2018.11.001_bb0150","series-title":"The obesity conundrum in sepsis","first-page":"147","volume":"17","author":"Ng","year":"2017"},{"key":"10.1016\/j.metabol.2018.11.001_bb0155","first-page":"665","article-title":"Overweight and obesity predict better overall survival rates in cancer patients with distant metastases","volume":"5","author":"Tsang","year":"2016","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0160","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1158\/0008-5472.CAN-17-3043","article-title":"The plausibility of obesity paradox in cancer-point","volume":"78","author":"Park","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2018.11.001_bb0165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5493\/wjem.v3.i3.26","article-title":"Interplay of adipokines and myokines in cancer pathophysiology: Emerging therapeutic implications","volume":"3","author":"Dalamaga","year":"2013","journal-title":"World J Exp Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb0170","first-page":"56","article-title":"The obesity paradox in cancer: a review","volume":"18","author":"Lennon","year":"2016","journal-title":"Eat Weight Disord"},{"key":"10.1016\/j.metabol.2018.11.001_bb0175","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/ijc.30248","article-title":"The use and interpretation of anthropometric measures in cancer epidemiology: A perspective from the world cancer research fund international continuous update project","volume":"139","author":"Bandera","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0180","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv088","article-title":"Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies","volume":"107","author":"Keum","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.metabol.2018.11.001_bb0185","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrc3967","article-title":"Adiposity and cancer risk: new mechanistic insights from epidemiology","volume":"15","author":"Renehan","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0190","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1463-1326.2011.01464.x","article-title":"Does intentional weight loss reduce cancer risk?","volume":"13","author":"Byers","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2018.11.001_bb0195","doi-asserted-by":"crossref","first-page":"R365","DOI":"10.1530\/ERC-15-0400","article-title":"Obesity and cancer: mechanistic insights from transdisciplinary studies","volume":"22","author":"Allott","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0200","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1467-789X.2012.01010.x","article-title":"A systematic review of the impact of weight loss on cancer incidence and mortality","volume":"13","author":"Birks","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0205","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1007\/s11695-016-2144-x","article-title":"Effects of bariatric surgery on mortality, cardiovascular events, and cancer outcomes in obese patients: systematic review and meta-analysis","volume":"26","author":"Zhou","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/j.metabol.2018.11.001_bb0210","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s11695-014-1276-0","article-title":"Incidence of cancer following bariatric surgery: systematic review and meta-analysis","volume":"24","author":"Casagrande","year":"2014","journal-title":"Obes Surg"},{"key":"10.1016\/j.metabol.2018.11.001_bb0215","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/CIR.0b013e31821c7c64","article-title":"Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American Heart Association","volume":"123","author":"Balagopal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2018.11.001_bb0220","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ijo.2008.11","article-title":"Accuracy of body mass index in diagnosing obesity in the adult general population","volume":"32","author":"Romero-Corral","year":"2008","journal-title":"Int J Obes"},{"key":"10.1016\/j.metabol.2018.11.001_bb0225","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/obr.12377","article-title":"A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis","volume":"17","author":"Cabia","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0230","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.metabol.2012.09.001","article-title":"Advances in adipokines","volume":"61","author":"Sahin-Efe","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2018.11.001_bb0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2217\/bmm.13.99","article-title":"Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives","volume":"8","author":"Dalamaga","year":"2014","journal-title":"Biomark Med"},{"issue":"4","key":"10.1016\/j.metabol.2018.11.001_bb0240","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s13679-018-0318-7","article-title":"Classic and novel adipocytokines at the intersection of obesity and cancer: diagnostic and therapeutic strategies","volume":"7","author":"Spyrou","year":"2018","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.metabol.2018.11.001_bb0245","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1373\/clinchem.2017.275172","article-title":"Addressing the perfect storm: biomarkers in obesity and pathophysiology of cardiometabolic risk","volume":"64","author":"Aleksandrova","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2018.11.001_bb0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2741\/E596","article-title":"Obesity and colorectal cancer","volume":"5","author":"Aleksandrova","year":"2013","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.metabol.2018.11.001_bb0255","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5493\/wjem.v3.i3.34","article-title":"Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets","volume":"3","author":"Dalamaga","year":"2013","journal-title":"World J Exp Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1470-2045(14)71123-4","article-title":"Global burden of cancer attributable to high body-mass index in 2012: a population-based study","volume":"16","author":"Arnold","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0265","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv210","article-title":"A prospective evaluation of endogenous sex hormone levels and colorectal cancer risk in postmenopausal women","volume":"107","author":"Murphy","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.metabol.2018.11.001_bb0270","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa032071","article-title":"Estrogen plus progestin and colorectal cancer in postmenopausal women","volume":"350","author":"Chlebowski","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb0275","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(09)70159-7","article-title":"Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial","volume":"10","author":"Sjostrom","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0280","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000066230","article-title":"The role of the IGF system in cancer: from basic to clinical studies and clinical applications","volume":"63","author":"Moschos","year":"2002","journal-title":"Oncology"},{"key":"10.1016\/j.metabol.2018.11.001_bb0285","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/CAD.0b013e32834258a1","article-title":"IGF system in cancer: from bench to clinic","volume":"22","author":"Chaves","year":"2011","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.metabol.2018.11.001_bb0290","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.beem.2008.08.011","article-title":"Acromegaly, growth hormone and cancer risk","volume":"22","author":"Renehan","year":"2008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2018.11.001_bb0295","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<15::AID-IJC4>3.0.CO;2-Y","article-title":"IGF-I and IGF-II in relation to colorectal cancer","volume":"83","author":"Manousos","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0300","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/bjc.1997.520","article-title":"Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia","volume":"76","author":"Mantzoros","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0305","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2018.11.001_bb0310","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1200\/JCO.2000.18.4.847","article-title":"Hormonal predictors of prostate cancer: a meta-analysis","volume":"18","author":"Shaneyfelt","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0315","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jnci\/90.12.911","article-title":"Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study","volume":"90","author":"Wolk","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.metabol.2018.11.001_bb0320","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.maturitas.2016.08.012","article-title":"Insulin growth factor (IGF) 1, IGF-binding proteins and ovarian cancer risk: a systematic review and meta-analysis","volume":"94","author":"Gianuzzi","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.metabol.2018.11.001_bb0325","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1159\/000438652","article-title":"Circulating Insulin-Like growth factor-1 level and ovarian cancer risk","volume":"38","author":"Li","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.metabol.2018.11.001_bb0330","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3892\/mco.2015.516","article-title":"Association of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 with the risk of ovarian cancer: A systematic review and meta-analysis","volume":"3","author":"Wang","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0335","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1152\/physrev.00030.2014","article-title":"Obesity and diabetes: the increased risk of cancer and cancer-related mortality","volume":"95","author":"Gallagher","year":"2015","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0340","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ijc.22697","article-title":"Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition","volume":"121","author":"Jenab","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0345","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/jnci\/92.19.1592","article-title":"Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women","volume":"92","author":"Kaaks","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.metabol.2018.11.001_bb0350","first-page":"164","article-title":"Insulin and colon cancer","volume":"6","author":"Giovannucci","year":"1995","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2018.11.001_bb0355","first-page":"687","article-title":"Epidemiology of colorectal cancer revisited: are serum triglycerides and\/or plasma glucose associated with risk?","volume":"3","author":"McKeown-Eyssen","year":"1994","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0360","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia: an update","volume":"12","author":"Pollak","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0365","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cellsig.2009.01.004","article-title":"Akt-dependent and -independent mechanisms of mTOR regulation in cancer","volume":"21","author":"Memmott","year":"2009","journal-title":"Cell Signal"},{"key":"10.1016\/j.metabol.2018.11.001_bb0370","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/mc.21878","article-title":"The enhancing effects of obesity on mammary tumor growth and Akt\/mTOR pathway activation persist after weight loss and are reversed by RAD001","volume":"52","author":"De Angel","year":"2013","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.metabol.2018.11.001_bb0375","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1158\/1940-6207.CAPR-08-0022","article-title":"Dietary energy balance modulates signaling through the Akt\/mammalian target of rapamycin pathways in multiple epithelial tissues","volume":"1","author":"Moore","year":"2008","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.metabol.2018.11.001_bb0380","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1530\/ERC-11-0213","article-title":"Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity","volume":"19","author":"Nogueira","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0385","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1210\/er.2008-0047","article-title":"Insulin receptor isoforms and insulin receptor\/insulin-like growth factor receptor hybrids in physiology and disease","volume":"30","author":"Belfiore","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0390","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/pros.20852","article-title":"Insulin receptor expression by human prostate cancers","volume":"69","author":"Cox","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.metabol.2018.11.001_bb0395","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mrfmmm.2013.03.006","article-title":"Insulin mediated DNA damage in mammalian colon cells and human lymphocytes in vitro","volume":"745-746","author":"Othman","year":"2013","journal-title":"Mutat Res"},{"key":"10.1016\/j.metabol.2018.11.001_bb0400","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/jnci\/djs399","article-title":"Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803","volume":"104","author":"Meyerhardt","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.metabol.2018.11.001_bb0405","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1038\/bjc.2014.150","article-title":"Does cancer risk increase with HbA1c, independent of diabetes?","volume":"110","author":"de Beer","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074179","article-title":"Diabetes protects from prostate cancer by downregulating androgen receptor: new insights from LNCaP cells and PAC120 mouse model","volume":"8","author":"Barbosa-Desongles","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.11.001_bb0415","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9610(88)80274-5","article-title":"Influence of diabetes on susceptibility to experimental pancreatic cancer","volume":"155","author":"Bell","year":"1988","journal-title":"Am J Surg"},{"key":"10.1016\/j.metabol.2018.11.001_bb0420","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0959-8049(97)10077-6","article-title":"An experimental model of diabetes and cancer in rats","volume":"34","author":"Cocca","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0425","first-page":"51","article-title":"Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice","volume":"67","author":"Shafie","year":"1981","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.metabol.2018.11.001_bb0430","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.med.0000433065.16918.83","article-title":"Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?","volume":"20","author":"Gallagher","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"Suppl. 2","key":"10.1016\/j.metabol.2018.11.001_bb0435","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.2337\/dcS13-2001","article-title":"Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer","volume":"36","author":"Gallagher","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2018.11.001_bb0440","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/1055-9965.EPI-10-0832","article-title":"Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis","volume":"19","author":"Crosbie","year":"2010","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0445","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/jnci\/djg022","article-title":"Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women","volume":"95","author":"Key","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.metabol.2018.11.001_bb0450","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/bcr3117","article-title":"Premenopausal serum androgens and breast cancer risk: a nested case-control study","volume":"14","author":"Zeleniuch-Jacquotte","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.metabol.2018.11.001_bb0455","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-319-42542-9_3","article-title":"Obesity and breast cancer","volume":"208","author":"Fortner","year":"2016","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.metabol.2018.11.001_bb0460","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-3-319-42542-9_7","article-title":"Obesity and endometrial cancer","volume":"208","author":"Shaw","year":"2016","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.metabol.2018.11.001_bb0465","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0470","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1749-6632.1991.tb37924.x","article-title":"Insulin-like growth factor-II (IGF-II) and IGF binding proteins in human endometrium","volume":"626","author":"Giudice","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.metabol.2018.11.001_bb0475","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1053\/j.gastro.2007.03.050","article-title":"The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas","volume":"132","author":"Giovannucci","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2018.11.001_bb0480","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb0485","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1158\/1055-9965.EPI-05-0633","article-title":"Circulating steroid hormones and the risk of prostate cancer","volume":"15","author":"Severi","year":"2006","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0490","doi-asserted-by":"crossref","first-page":"40554","DOI":"10.1038\/srep40554","article-title":"Androgen receptor gene polymorphisms and risk of prostate cancer: a meta-analysis","volume":"7","author":"Weng","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2018.11.001_bb0495","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1016\/j.metabol.2017.12.015","article-title":"Inflammation: a key player linking obesity with malignancies","volume":"81","author":"Boutari","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2018.11.001_bb0500","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-pathol-012615-044359","article-title":"Obesity, inflammation, and cancer","volume":"11","author":"Deng","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0505","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1158\/1055-9965.EPI-14-0240","article-title":"Metabolic health reduces risk of obesity-related cancer in framingham study adults","volume":"23","author":"Moore","year":"2014","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0510","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","article-title":"Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex","volume":"46","author":"Cnop","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2018.11.001_bb0515","doi-asserted-by":"crossref","first-page":"E527","DOI":"10.1152\/ajpendo.00110.2003","article-title":"Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans","volume":"285","author":"Bruun","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2018.11.001_bb0520","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-130-8-199904200-00014","article-title":"The role of leptin in human obesity and disease: a review of current evidence","volume":"130","author":"Mantzoros","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb0525","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.biochi.2012.05.018","article-title":"Immunological functions of leptin and adiponectin","volume":"94","author":"Carbone","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.metabol.2018.11.001_bb0530","first-page":"1451","article-title":"B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case-control study in Greece","volume":"21","author":"Dalamaga","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2018.11.001_bb0535","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.metabol.2013.09.007","article-title":"Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome","volume":"62","author":"Dalamaga","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2018.11.001_bb0540","first-page":"625","article-title":"Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study","volume":"20","author":"Dalamaga","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2018.11.001_bb0545","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000120995","article-title":"Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study","volume":"73","author":"Dalamaga","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.metabol.2018.11.001_bb0550","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jc.2003-031804","article-title":"Adiponectin and breast cancer risk","volume":"89","author":"Mantzoros","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2018.11.001_bb0555","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI96139","article-title":"Insulin resistance causes inflammation in adipose tissue","volume":"128","author":"Shimobayashi","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2018.11.001_bb0560","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.metabol.2017.11.014","article-title":"Impact of systemic inflammation on the relationship between insulin resistance and all-cause and cancer-related mortality","volume":"81","author":"Lee","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2018.11.001_bb0565","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2012.46.3653","article-title":"Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers","volume":"31","author":"Jain","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0570","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/hc0702.104279","article-title":"Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year","volume":"105","author":"Ziccardi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2018.11.001_bb0575","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.metabol.2017.01.030","article-title":"The short-term and long-term effects of bariatric\/metabolic surgery on subcutaneous adipose tissue inflammation in humans","volume":"70","author":"Hagman","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2018.11.001_bb0580","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb0585","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","article-title":"Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion","volume":"71","author":"Dirat","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2018.11.001_bb0590","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc3803","article-title":"Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?","volume":"14","author":"Sabharwal","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0595","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1089\/ars.2012.4604","article-title":"Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease","volume":"19","author":"Dikalov","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.metabol.2018.11.001_bb0600","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1158\/0008-5472.CAN-13-3603","article-title":"NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions","volume":"74","author":"Bowers","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2018.11.001_bb0605","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10549-014-3030-7","article-title":"Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women","volume":"146","author":"Cui","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.metabol.2018.11.001_bb0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114633","article-title":"Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study","volume":"9","author":"Shebl","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.11.001_bb0615","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1590\/1414-431X20132911","article-title":"New concepts in white adipose tissue physiology","volume":"47","author":"Proenca","year":"2014","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.metabol.2018.11.001_bb0620","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.orcp.2018.01.005","article-title":"The mechanisms linking obesity to colon cancer: an overview","volume":"12","author":"Tarasiuk","year":"2018","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.metabol.2018.11.001_bb0625","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.7150\/jca.16884","article-title":"Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation","volume":"7","author":"Divella","year":"2016","journal-title":"J Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0630","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1515\/hmbci-2014-0045","article-title":"Adipose tissue dysfunction and its effects on tumor metabolism","volume":"21","author":"Diedrich","year":"2015","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.metabol.2018.11.001_bb0635","first-page":"65","article-title":"Mechanisms linking excess adiposity and carcinogenesis promotion","volume":"5","author":"Perez-Hernandez","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2018.11.001_bb0640","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity and cancer mechanisms: tumor microenvironment and inflammation","volume":"34","author":"Iyengar","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0645","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1158\/0008-5472.CAN-13-0530","article-title":"Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer","volume":"73","author":"Bochet","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2018.11.001_bb0650","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb0655","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1038\/ncomms10230","article-title":"Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity","volume":"7","author":"Laurent","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2018.11.001_bb0660","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1161\/CIRCULATIONAHA.111.077602","article-title":"Ectopic fat depots and cardiovascular disease","volume":"124","author":"Britton","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2018.11.001_bb0665","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1515\/hmbci-2015-0016","article-title":"Adiponectin as a biomarker linking obesity and adiposopathy to hematologic malignancies","volume":"23","author":"Dalamaga","year":"2015","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.metabol.2018.11.001_bb0670","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/bjs.9623","article-title":"Excess adiposity and gastrointestinal cancer","volume":"101","author":"Coe","year":"2014","journal-title":"Br J Surg"},{"key":"10.1016\/j.metabol.2018.11.001_bb0675","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cmet.2011.10.011","article-title":"The inflammasome puts obesity in the danger zone","volume":"15","author":"Stienstra","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2018.11.001_bb0680","doi-asserted-by":"crossref","first-page":"15324","DOI":"10.1073\/pnas.1100255108","article-title":"Inflammasome is a central player in the induction of obesity and insulin resistance","volume":"108","author":"Stienstra","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2018.11.001_bb0685","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fonc.2015.00157","article-title":"Cross-talk between adiponectin and IGF-IR in breast cancer","volume":"5","author":"Mauro","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0690","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1200\/JCO.2016.67.9712","article-title":"Obesity and cancer mechanisms: cancer metabolism","volume":"34","author":"Hopkins","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0695","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.ejca.2008.04.015","article-title":"Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system","volume":"44","author":"Dalamaga","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0700","first-page":"193","article-title":"Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study","volume":"20","author":"Dalamaga","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2018.11.001_bb0705","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011433","article-title":"Serum adiponectin in breast cancer: a meta-analysis","volume":"97","author":"Gu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.metabol.2018.11.001_bb0710","article-title":"The role of adiponectin in breast cancer: a meta-analysis","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.11.001_bb0715","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2147\/OTT.S157255","article-title":"Low circulating total adiponectin, especially its non-high-molecular weight fraction, represents a promising risk factor for colorectal cancer: a meta-analysis","volume":"11","author":"Lu","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.metabol.2018.11.001_bb0720","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4103\/0973-1482.186695","article-title":"Serum adiponectin levels are inversely correlated with leukemia: a meta-analysis","volume":"12","author":"Ma","year":"2016","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.metabol.2018.11.001_bb0725","doi-asserted-by":"crossref","first-page":"48671","DOI":"10.18632\/oncotarget.8932","article-title":"Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies","volume":"7","author":"Wei","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.metabol.2018.11.001_bb0730","article-title":"Circulating adiponectin and risk of endometrial cancer","volume":"10","author":"Zheng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.11.001_bb0735","first-page":"2352","article-title":"Inflammation and obesity (lipoinflammation)","volume":"31","author":"Izaola","year":"2015","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.metabol.2018.11.001_bb0740","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.11.001_bb0745","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/jnci\/djs032","article-title":"Angiopoietin2 and tie2: tied to lymphangiogenesis and lung metastasis. New perspectives in antimetastatic antiangiogenic therapy","volume":"104","author":"Albini","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.metabol.2018.11.001_bb0750","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10555-007-9108-5","article-title":"Inflammation, inflammatory cells and angiogenesis: decisions and indecisions","volume":"27","author":"Noonan","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0755","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"Folkman","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0760","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.11.001_bb0765","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-med-121211-091527","article-title":"Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression","volume":"64","author":"Gilbert","year":"2013","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb0770","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1749-6632.2012.06737.x","article-title":"Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue","volume":"1271","author":"Hursting","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.metabol.2018.11.001_bb0775","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","article-title":"Smoldering and polarized inflammation in the initiation and promotion of malignant disease","volume":"7","author":"Balkwill","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.metabol.2018.11.001_bb0780","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1467-789X.2012.01024.x","article-title":"Mechanisms linking obesity, inflammation and altered metabolism to colon carcinogenesis","volume":"13","author":"Yehuda-Shnaidman","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0785","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccr.2014.03.015","article-title":"Endoplasmic reticulum stress in malignancy","volume":"25","author":"Clarke","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.metabol.2018.11.001_bb0790","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/bjc.2014.657","article-title":"Stem cells from adipose tissue and breast cancer: hype, risks and hope","volume":"112","author":"Bertolini","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0795","first-page":"97","article-title":"Obesity linking to hepatocellular carcinoma: a global view","volume":"2018","author":"Gan","year":"1869","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2018.11.001_bb0800","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MED.0000000000000082","article-title":"Metabolic effects of sleep disruption, links to obesity and diabetes","volume":"21","author":"Nedeltcheva","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.metabol.2018.11.001_bb0805","first-page":"1744","article-title":"Circulating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: evidence of an altered circadian rhythm","volume":"88","author":"Buzzelli","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0810","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/jnci\/82.12.1046","article-title":"Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate","volume":"82","author":"Caussanel","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.metabol.2018.11.001_bb0815","first-page":"207","article-title":"Breast cancer and circadian disruption from electric lighting in the modern world","volume":"64","author":"Stevens","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.metabol.2018.11.001_bb0820","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3109\/10715762.2011.582869","article-title":"Cancer and diet: how are they related?","volume":"45","author":"Sung","year":"2011","journal-title":"Free Radic Res"},{"key":"10.1016\/j.metabol.2018.11.001_bb0825","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jnci\/djj071","article-title":"Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC)","volume":"98","author":"Gonzalez","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.metabol.2018.11.001_bb0830","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/jnci\/djj246","article-title":"Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC)","volume":"98","author":"Pischon","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.metabol.2018.11.001_bb0835","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0140-6736(03)13174-1","article-title":"Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study","volume":"361","author":"Bingham","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2018.11.001_bb0840","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1158\/1055-9965.EPI-04-0891","article-title":"Is the association with fiber from foods in colorectal cancer confounded by folate intake?","volume":"14","author":"Bingham","year":"2005","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09637486.2014.950207","article-title":"Diet and breast cancer: a systematic review","volume":"66","author":"Mourouti","year":"2015","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.metabol.2018.11.001_bb0850","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/bjc.2015.153","article-title":"Mediterranean diet and risk of endometrial cancer: a pooled analysis of three Italian case-control studies","volume":"112","author":"Filomeno","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0855","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/1055-9965.EPI-13-0515","article-title":"Dietary intake and ovarian cancer risk: a systematic review","volume":"23","author":"Crane","year":"2014","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0860","first-page":"125","article-title":"Consumption of different types of meat and the risk of renal cancer: meta-analysis of case-control studies","volume":"18","author":"Faramawi","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2018.11.001_bb0865","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12032-014-0125-2","article-title":"Dietary fiber intake and risk of renal cell carcinoma: evidence from a meta-analysis","volume":"31","author":"Huang","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0870","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/CEJ.0000000000000015","article-title":"Sweetened carbonated beverage consumption and cancer risk: meta-analysis and review","volume":"23","author":"Boyle","year":"2014","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0875","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/ejcn.2012.135","article-title":"Magnesium intake and risk of colorectal cancer: a meta-analysis of prospective studies","volume":"66","author":"Chen","year":"2012","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.metabol.2018.11.001_bb0880","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1158\/1055-9965.EPI-10-0407","article-title":"Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk","volume":"19","author":"Eussen","year":"2010","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.metabol.2018.11.001_bb0885","doi-asserted-by":"crossref","first-page":"b5500","DOI":"10.1136\/bmj.b5500","article-title":"Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study","volume":"340","author":"Jenab","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2018.11.001_bb0890","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1001\/jama.2010.808","article-title":"Serum B vitamin levels and risk of lung cancer","volume":"303","author":"Johansson","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2018.11.001_bb0895","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/carcin\/bgl096","article-title":"Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)","volume":"27","author":"Jenab","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.metabol.2018.11.001_bb0900","first-page":"699","article-title":"Antioxidant vitamins and the risk of endometrial cancer: a dose-response meta-analysis","volume":"20","author":"Bandera","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2018.11.001_bb0905","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1002\/ijc.29277","article-title":"Dietary supplement use and colorectal cancer risk: a systematic review and meta-analyses of prospective cohort studies","volume":"136","author":"Heine-Broring","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb0910","series-title":"An integrated catalog of reference genes in the human gut microbiome","first-page":"834","volume":"32","author":"Li","year":"2014"},{"key":"10.1016\/j.metabol.2018.11.001_bb0915","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002836","article-title":"Comparative analysis of human gut microbiota by barcoded pyrosequencing","volume":"3","author":"Andersson","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.11.001_bb0920","doi-asserted-by":"crossref","first-page":"986734","DOI":"10.1155\/2013\/986734","article-title":"Influence of gut microbiota on subclinical inflammation and insulin resistance","volume":"2013","author":"Carvalho","year":"2013","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.metabol.2018.11.001_bb0925","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1053\/j.gastro.2009.08.042","article-title":"High-fat diet determines the composition of the murine gut microbiome independently of obesity","volume":"137","author":"Hildebrandt","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2018.11.001_bb0930","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1073\/pnas.0504978102","article-title":"Obesity alters gut microbial ecology","volume":"102","author":"Ley","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2018.11.001_bb0935","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1017\/S0007114512005612","article-title":"Changes in gut microbiota due to supplemented fatty acids in diet-induced obese mice","volume":"110","author":"Mujico","year":"2013","journal-title":"Br J Nutr"},{"key":"10.1016\/j.metabol.2018.11.001_bb0940","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.chom.2008.02.015","article-title":"Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome","volume":"3","author":"Turnbaugh","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.metabol.2018.11.001_bb0945","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.11.001_bb0950","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1073\/pnas.0812600106","article-title":"Human gut microbiota in obesity and after gastric bypass","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2018.11.001_bb0955","doi-asserted-by":"crossref","first-page":"1241214","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.metabol.2018.11.001_bb0960","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41575-018-0025-6","article-title":"Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer","volume":"15","author":"Cani","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2018.11.001_bb0965","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.07.013","article-title":"IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer","volume":"118","author":"Greten","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2018.11.001_bb0970","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/156652410791316968","article-title":"Molecular pathways linking inflammation and cancer","volume":"10","author":"Mantovani","year":"2010","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb0975","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature02924","article-title":"NF-kappaB functions as a tumour promoter in inflammation-associated cancer","volume":"431","author":"Pikarsky","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.11.001_bb0980","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2018.11.001_bb0985","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1038\/onc.2013.302","article-title":"The yin and yang of toll-like receptors in cancer","volume":"33","author":"Pradere","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.metabol.2018.11.001_bb0990","doi-asserted-by":"crossref","first-page":"259","DOI":"10.15252\/emmm.201404169","article-title":"Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance","volume":"7","author":"Denou","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb0995","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.suc.2017.01.010","article-title":"Dysplasia and cancer in inflammatory bowel disease","volume":"97","author":"Huang","year":"2017","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.metabol.2018.11.001_bb1000","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"White","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2018.11.001_bb1005","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/gutjnl-2016-312729","article-title":"Gut microbiome and liver diseases","volume":"65","author":"Tilg","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2018.11.001_bb1010","doi-asserted-by":"crossref","first-page":"31802","DOI":"10.18632\/oncotarget.15992","article-title":"Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4\/P-PAK1 cascade","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.metabol.2018.11.001_bb1015","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.gastro.2016.11.018","article-title":"Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-kappaB, and up-regulating expression of MicroRNA-21","volume":"152","author":"Yang","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2018.11.001_bb1020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","article-title":"Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment","volume":"14","author":"Kostic","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.metabol.2018.11.001_bb1025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053653","article-title":"Fusobacterium is associated with colorectal adenomas","volume":"8","author":"McCoy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.11.001_bb1030","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1158\/0008-5472.CAN-14-2732","article-title":"Dietary microbes modulate transgenerational cancer risk","volume":"75","author":"Poutahidis","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2018.11.001_bb1035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.11.001_bb1040","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/carcin\/22.6.957","article-title":"Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation","volume":"22","author":"Qiao","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.metabol.2018.11.001_bb1045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/carcin\/bgl139","article-title":"Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells","volume":"28","author":"Payne","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.metabol.2018.11.001_bb1050","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2011.02.018","article-title":"The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon","volume":"13","author":"Donohoe","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2018.11.001_bb1055","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1038\/ncomms5718","article-title":"Functional high-throughput screening identifies the miR-15 microRNA family as cellular restriction factors for Salmonella infection","volume":"5","author":"Maudet","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2018.11.001_bb1060","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","article-title":"Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy","volume":"170","author":"Yu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2018.11.001_bb1065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2007.04.046","article-title":"Abdominal obesity and body mass index as risk factors for Barrett's esophagus","volume":"133","author":"Corley","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2018.11.001_bb1070","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.3748\/wjg.v19.i39.6536","article-title":"Gastro-esophageal reflux disease and obesity, where is the link?","volume":"19","author":"Emerenziani","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2018.11.001_bb1075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.gtc.2013.11.009","article-title":"Obesity and GERD","volume":"43","author":"Chang","year":"2014","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.metabol.2018.11.001_bb1080","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/sj.ijo.0802437","article-title":"Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study","volume":"27","author":"Parker","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.metabol.2018.11.001_bb1085","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/oxfordjournals.aje.a117386","article-title":"Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years","volume":"141","author":"Williamson","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.metabol.2018.11.001_bb1090","first-page":"Cd003817","article-title":"Exercise for overweight or obesity","author":"Shaw","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.metabol.2018.11.001_bb1095","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/oby.20318","article-title":"Young adult weight trajectories through midlife by body mass category","volume":"21","author":"Malhotra","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2018.11.001_bb1100","doi-asserted-by":"crossref","first-page":"E1197","DOI":"10.1152\/ajpendo.00357.2009","article-title":"A very low carbohydrate ketogenic diet improves glucose tolerance in ob\/ob mice independently of weight loss","volume":"297","author":"Badman","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2018.11.001_bb1105","doi-asserted-by":"crossref","first-page":"E1724","DOI":"10.1152\/ajpendo.00717.2006","article-title":"A high-fat, ketogenic diet induces a unique metabolic state in mice","volume":"292","author":"Kennedy","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2018.11.001_bb1110","doi-asserted-by":"crossref","first-page":"1320s","DOI":"10.3945\/ajcn.114.084038","article-title":"The role of protein in weight loss and maintenance","volume":"101","author":"Leidy","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2018.11.001_bb1115","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ejcn.2013.116","article-title":"Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets","volume":"67","author":"Paoli","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.metabol.2018.11.001_bb1120","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa1307352","article-title":"Association of nut consumption with total and cause-specific mortality","volume":"369","author":"Bao","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb1125","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2017.75.5413","article-title":"Nut consumption and survival in patients with stage III colon cancer: results from CALGB 89803 (Alliance)","volume":"36","author":"Fadelu","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb1130","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cam4.539","article-title":"Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis of observational studies","volume":"4","author":"Schwingshackl","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb1135","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2174\/138161211795428920","article-title":"Olive oil and cancer risk: an update of epidemiological findings through 2010","volume":"17","author":"Pelucchi","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.metabol.2018.11.001_bb1140","series-title":"Curcumin: a naturally occurring modulator of adipokines in diabetes","first-page":"4170","volume":"118","author":"Hajavi","year":"2017"},{"key":"10.1016\/j.metabol.2018.11.001_bb1145","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa1700459","article-title":"Weight and metabolic outcomes 12\u202fyears after gastric bypass","volume":"377","author":"Adams","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb1150","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s11695-015-1764-x","article-title":"The changing bariatric surgery landscape in the USA","volume":"25","author":"Spaniolas","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/j.metabol.2018.11.001_bb1155","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/dom.12922","article-title":"Short- and long-term mortality after bariatric surgery: a systematic review and meta-analysis","volume":"19","author":"Cardoso","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2018.11.001_bb1160","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.soard.2008.08.025","article-title":"Bariatric surgery reduces cancer risk in morbidly obese patients","volume":"4","author":"Christou","year":"2008","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.metabol.2018.11.001_bb1165","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/oby.2008.610","article-title":"Cancer incidence and mortality after gastric bypass surgery","volume":"17","author":"Adams","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2018.11.001_bb1170","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jhep.2009.06.016","article-title":"Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression","volume":"51","author":"Moschen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2018.11.001_bb1175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/07853890.2012.727020","article-title":"Nordic walking decreased circulating chemerin and leptin concentrations in middle-aged men with impaired glucose regulation","volume":"45","author":"Venojarvi","year":"2013","journal-title":"Ann Med"},{"key":"10.1016\/j.metabol.2018.11.001_bb1180","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MPA.0000000000000974","article-title":"Obesity and pancreatic cancer: overview of epidemiology and potential prevention by weight loss","volume":"47","author":"Xu","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.metabol.2018.11.001_bb1185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.diabres.2018.05.023","article-title":"Metformin in cancer","volume":"143","author":"Mallik","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metabol.2018.11.001_bb1190","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1055\/s-0028-1082040","article-title":"Intensive glycemic control lowers plasma visfatin levels in patients with type 2 diabetes","volume":"40","author":"Zhu","year":"2008","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.metabol.2018.11.001_bb1195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1515\/hsz-2017-0271","article-title":"Metformin-induced anticancer activities: recent insights","volume":"399","author":"Safe","year":"2018","journal-title":"Biol Chem"},{"key":"10.1016\/j.metabol.2018.11.001_bb1200","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/1535-7163.MCT-09-1186","article-title":"Metformin in cancer therapy: a new perspective for an old antidiabetic drug?","volume":"9","author":"Ben Sahra","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.metabol.2018.11.001_bb1205","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(15)00565-3","article-title":"Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial","volume":"17","author":"Higurashi","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb1210","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/dc08-2175","article-title":"New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes","volume":"32","author":"Libby","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2018.11.001_bb1215","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.metabol.2018.11.001_bb1220","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1940-6207.CAPR-13-0424","article-title":"Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders","volume":"7","author":"Gandini","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.metabol.2018.11.001_bb1225","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-017-4372-6","article-title":"Repurposing metformin for the prevention of cancer and cancer recurrence","volume":"60","author":"Heckman-Stoddard","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2018.11.001_bb1230","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/annonc\/mdw410","article-title":"Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis","volume":"27","author":"Coyle","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb1235","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fonc.2018.00341","article-title":"Metformin as a therapeutic target in endometrial cancers","volume":"8","author":"Lee","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb1240","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1517\/14740338.2015.1084289","article-title":"Metformin: risk-benefit profile with a focus on cancer","volume":"14","author":"Provinciali","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.metabol.2018.11.001_bb1245","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3332\/ecancer.2015.554","article-title":"Why does obesity promote cancer? Epidemiology, biology, and open questions","volume":"9","author":"Mazzarella","year":"2015","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.metabol.2018.11.001_bb1250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.critrevonc.2016.06.006","article-title":"Metformin use and gynecological cancers: a novel treatment option emerging from drug repositioning","volume":"105","author":"Gadducci","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.metabol.2018.11.001_bb1255","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fendo.2017.00031","article-title":"PPAR-gamma agonists as antineoplastic agents in cancers with dysregulated IGF axis","volume":"8","author":"Vella","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2018.11.001_bb1260","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4149\/gpb_2017045","article-title":"The role of statins as therapeutic agents in cancer","volume":"36","author":"Sopkova","year":"2017","journal-title":"Gen Physiol Biophys"},{"key":"10.1016\/j.metabol.2018.11.001_bb1265","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ygyno.2017.10.026","article-title":"Aspirin use and endometrial cancer risk and survival","volume":"148","author":"Takiuchi","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.metabol.2018.11.001_bb1270","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.metabol.2018.11.001_bb1275","series-title":"U.S. preventive services task force evidence syntheses, formerly systematic evidence reviews. Use of aspirin and NSAIDs to prevent colorectal cancer","author":"Rostom","year":"2007"},{"key":"10.1016\/j.metabol.2018.11.001_bb1280","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biocel.2016.08.023","article-title":"Leptin-induced transphosphorylation of vascular endothelial growth factor receptor increases Notch and stimulates endothelial cell angiogenic transformation","volume":"79","author":"Lanier","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.metabol.2018.11.001_bb1285","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/bcr2321","article-title":"Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer","volume":"11","author":"Rene Gonzalez","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.metabol.2018.11.001_bb1290","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cytogfr.2013.10.001","article-title":"Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets","volume":"24","author":"Khan","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.metabol.2018.11.001_bb1295","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/bip.22627","article-title":"Optimization of adiponectin-derived peptides for inhibition of cancer cell growth and signaling","volume":"104","author":"Otvos","year":"2015","journal-title":"Biopolymers"},{"key":"10.1016\/j.metabol.2018.11.001_bb1300","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1158\/1940-6207.CAPR-15-0175","article-title":"Prediagnostic plasma adiponectin and survival among patients with colorectal cancer","volume":"8","author":"Chong","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.metabol.2018.11.001_bb1305","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.clinbiochem.2013.01.001","article-title":"Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters","volume":"46","author":"Dalamaga","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.metabol.2018.11.001_bb1310","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1210\/jc.2006-1975","article-title":"Plasma adiponectin concentrations and risk of incident breast cancer","volume":"92","author":"Tworoger","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2018.11.001_bb1315","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.maturitas.2011.12.013","article-title":"Could serum visfatin be a potential biomarker for postmenopausal breast cancer?","volume":"71","author":"Dalamaga","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.metabol.2018.11.001_bb1320","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/CIRCIMAGING.110.956706","article-title":"Prevalence, distribution, and risk factor correlates of high pericardial and intrathoracic fat depots in the Framingham heart study","volume":"3","author":"Thanassoulis","year":"2010","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049518302324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049518302324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:20:47Z","timestamp":1758428447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049518302324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":264,"alternative-id":["S0026049518302324"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2018.11.001","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity and cancer risk: Emerging biological mechanisms and perspectives","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2018.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}